RAD51 and familial pancreatic carcinoma: Pretreatment by Rad51-inhibitory substances such as gemcitabine followed by arterial chemotherapy using antineoplastic agents causing DNA, DSB, or DNA crosslink might be more beneficial for patients with locally advanced pancreatic cancers than conventional treatments.